Comparison of Point of Care (POC) Testing of Glucose by B Braun Glucometer and Hemocue Glucose 201+ Analyser Versus Centralised Testing in Neonatal Intensive Care Unit (NICU)
- PMID: 25177612
- PMCID: PMC4149118
- DOI: 10.7860/JCDR/2014/8666.4538
Comparison of Point of Care (POC) Testing of Glucose by B Braun Glucometer and Hemocue Glucose 201+ Analyser Versus Centralised Testing in Neonatal Intensive Care Unit (NICU)
Abstract
Background: Neonatal hypoglycemia is the most common carbohydrate metabolic disturbance seen in case of neonates and especially in preterm neonates. Accurate and rapid determination of hypoglycemia and its prompt treatment is of utmost importance to decrease morbidity and mortality of neonates.
Aims: To estimate blood glucose in neonates and test the efficacy of HemoCue Glucose 201+ analyser and B Braun Glucometer by comparing with centralised laboratory testing. To compare the blood glucose in capillary and venous blood samples of neonates.
Settings and design: Hospital setting; Comparative Study Materials and Methods: After obtaining informed consent, all neonates admitted to Neonatal Intensive Care Unit (NICU) were screened for blood sugar. Capillary and venous blood glucose was estimated employing HemoCue Glucose 201+ analyser and B Braun Glucometer. Simultaneously, the same venous sample was collected in fluoride tube and sent to central clinical biochemistry laboratory for glucose estimation. When anaemia or polycythemia was clinically suspected the same venous sample was sent for estimation of Hematocrit (Hct).
Statistical analysis: Comparison of blood glucose concentration of B Braun glucometer, HemoCue Glucose 201+ analyser and centralis/ed plasma glucose levels was done by using students test. All the statistical analysis were done using software SPSS 6 version.
Results: Mean values of blood glucose (100.2 + 48.4) with B Braun glucometer was significantly higher (p=0.003) when compared to plasma glucose values (76.95 + 45.99) estimated in central laboratory and HemoCue glucose 201+ analyser (82.9 + 51.4). HemoCue glucose 201+ analyser did not show significant difference (p=0.463) with central laboratory testing. There was no significant difference between the capillary and venous sample estimated in both the instruments. Estimation with HemoCue glucose 201+ analyser correlated well with central laboratory testing in neonates with blood glucose <55mg/dl,
Conclusion: We conclude that HemoCue glucose 201+ analyser appears to be a suitable point of care (POC) blood glucose measurement device in neonates on both capillary and venous blood samples, as it showed a good correlation with central laboratory values without significant interference from Hct.
Keywords: B Braun glucometer; Blood glucose; HemoCue glucose 201+ analyser; Point of care testing.
Similar articles
-
Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit.Clin Chem Lab Med. 2007;45(11):1549-54. doi: 10.1515/CCLM.2007.302. Clin Chem Lab Med. 2007. PMID: 17970709
-
Capillary versus venous bedside blood glucose estimations.Emerg Med J. 2005 Mar;22(3):177-9. doi: 10.1136/emj.2003.011619. Emerg Med J. 2005. PMID: 15735263 Free PMC article.
-
Assessment of haemoglobin measurement by several methods - blood gas analyser, capillary and venous HemoCue® , non-invasive spectrophotometry and laboratory assay - in term and preterm infants.Anaesthesia. 2019 Feb;74(2):197-202. doi: 10.1111/anae.14481. Epub 2018 Nov 14. Anaesthesia. 2019. PMID: 30427065
-
Evaluation of a continuous glucose monitoring system compared with an in-house standard laboratory assay and a handheld point-of-care glucometer in critically ill neonatal foals.J Vet Emerg Crit Care (San Antonio). 2013 Jul-Aug;23(4):408-15. doi: 10.1111/vec.12072. Epub 2013 Jul 16. J Vet Emerg Crit Care (San Antonio). 2013. PMID: 23859299
-
Comparison of EML 105 and advantage analysers measuring capillary versus venous whole blood glucose in neonates.Acta Paediatr. 2001 Sep;90(9):1033-41. doi: 10.1080/080352501316978129. Acta Paediatr. 2001. PMID: 11683192
Cited by
-
Effect of a Whey Protein Supplement on Preservation of Fat Free Mass in Overweight and Obese Individuals on an Energy Restricted Very Low Caloric Diet.Nutrients. 2018 Dec 4;10(12):1918. doi: 10.3390/nu10121918. Nutrients. 2018. PMID: 30518130 Free PMC article. Clinical Trial.
-
Improving physical activity, pain and function in patients waiting for hip and knee arthroplasty by combining targeted exercise training with behaviour change counselling: study protocol for a randomised controlled trial.Trials. 2018 Aug 7;19(1):425. doi: 10.1186/s13063-018-2808-z. Trials. 2018. PMID: 30086780 Free PMC article.
References
-
- Wilker RE. Manual of Neonatal Care. 6th ed. Vol. 6. Philadelphia: Lippincott, Williams and Wilkins; 2008. Hypoglycemia and hyperglycemia. In Cloherty JP, Eichenwald EC, Stark AR (eds) pp. 540–49.
-
- Passey RB, Gillum RL, Fuller JB, Urry FM, Giles ML. Evaluation and comparison of glucose methods and the reference method recommended in the proposed product class standard (1974) Clin Chem. 1977;203:131–39. - PubMed
-
- Adamkin DH. Committee on Fetus and Newborn. Postnatal glucose hemostasis in late preterm and term infants. Pediatrics. 2011;127:575–79. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources